223 related articles for article (PubMed ID: 29876773)
1. Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013-2015.
Henriksen AS; Smart J; Hamed K
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1653-1659. PubMed ID: 29876773
[TBL] [Abstract][Full Text] [Related]
2. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06.
Hope R; Livermore DM; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii65-74. PubMed ID: 18819981
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
[TBL] [Abstract][Full Text] [Related]
5. Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance data.
Horner C; Mushtaq S; Livermore DM;
J Antimicrob Chemother; 2020 Nov; 75(11):3239-3243. PubMed ID: 32728710
[TBL] [Abstract][Full Text] [Related]
6. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China.
Cui J; Liang Z; Mo Z; Zhang J
Antimicrob Resist Infect Control; 2019; 8():65. PubMed ID: 31044070
[TBL] [Abstract][Full Text] [Related]
7. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Mashaly GE; El-Mahdy RH
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
[TBL] [Abstract][Full Text] [Related]
9. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
10. Coagulase-negative staphylococci in outpatient routines: the implications of switching from CLSI to BrCAST/EUCAST guidelines.
Perez VP; Carvalho JKBP; de Oliveira MS; Rossato AM; Dani C; Corção G; d'Azevedo PA
Braz J Microbiol; 2020 Sep; 51(3):1071-1078. PubMed ID: 32328965
[TBL] [Abstract][Full Text] [Related]
11. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
Mendes RE; Sader HS; Jones RN
Int J Antimicrob Agents; 2010 Oct; 36(4):374-9. PubMed ID: 20598860
[TBL] [Abstract][Full Text] [Related]
12. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.
Livermore DM; Hope R; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii41-54. PubMed ID: 18819979
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015).
Pfaller MA; Flamm RK; Duncan LR; Streit JM; Castanheira M; Sader HS
Diagn Microbiol Infect Dis; 2018 May; 91(1):77-84. PubMed ID: 29395713
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey.
Koksal F; Yasar H; Samasti M
Microbiol Res; 2009; 164(4):404-10. PubMed ID: 17475456
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
Lascols C; Legrand P; Mérens A; Leclercq R; Muller-Serieys C; Drugeon HB; Kitzis MD; Reverdy ME; Roussel-Delvallez M; Moubareck C; Brémont S; Miara A; Gjoklaj M; Soussy CJ
Int J Antimicrob Agents; 2011 Mar; 37(3):235-9. PubMed ID: 21295447
[TBL] [Abstract][Full Text] [Related]
16. Coagulase-negative staphylococci causing blood stream infection at an Indian tertiary care hospital: Prevalence, antimicrobial resistance and molecular characterisation.
Singh S; Dhawan B; Kapil A; Kabra SK; Suri A; Sreenivas V; Das BK
Indian J Med Microbiol; 2016; 34(4):500-505. PubMed ID: 27934830
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and genetic mechanisms of antimicrobial resistance in
Rajkumar S; Sistla S; Manoharan M; Sugumar M; Nagasundaram N; Parija SC; Ray P; Bakthavatchalam YD; Veeraraghavan B; Kapil A; Walia K; Ohri VC
Indian J Med Microbiol; 2017; 35(1):53-60. PubMed ID: 28303819
[TBL] [Abstract][Full Text] [Related]
18. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
Farrell DJ; Flamm RK; Sader HS; Jones RN
Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility and body site distribution of community isolates of coagulase-negative staphylococci.
Cavanagh JP; Wolden R; Heise P; Esaiassen E; Klingenberg C; Aarag Fredheim EG
APMIS; 2016 Nov; 124(11):973-978. PubMed ID: 27599662
[TBL] [Abstract][Full Text] [Related]
20. Detection of methicillin resistance in coagulase-negative staphylococci by cefoxitin disc diffusion and oxacillin Etest. A study of consecutive bacteraemia isolates.
Hederstierna-Johnsen T; Schønheyder HC; Paulsen K
APMIS; 2005 Oct; 113(10):688-92. PubMed ID: 16309428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
